Glass syringes segment by type is estimated to lead the market growth during the forecast period
According to a new market research study of “Asia Pacific Syringe Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Syringe Type, Application, Usability, and End User” the Asia Pacific syringe market is projected to reach US$5,946.66 million by 2027 from US$2,654.58 million in 2019. The market is estimated to grow at CAGR of 10.5% from 2020 to 2027. The report highlights trends prevailing in the Asia Pacific syringe market and the factors driving market along with those that act as hindrances.
Based on syringe type, the syringe market is segmented into luer lock syringes, glass syringes, luer slip syringes, and others.
In 2019, the Luer-Lock syringes segment accounted for the highest share of the market in 2019. However, the glass syringes segment is estimated to register the highest CAGR of 11.3% in the market during the forecast period. Growth of this segment is attributed to the increasing adoption of luer lock syringes due to ease of administration and increasing patient pool across the globe. However, glass syringes are likely to register highest CAGR in the global syringes market during the forecast period.
The Luer-Lock syringes used for essential clinical applications in which disengagement of needle is to be avoided in order to prevent medication leakage or spray. A Luer lock syringe allows screw-fixation and is therefore a more convenient to inject. Luer lock syringes are more widely used for using a syringe pump for prolonged IV infusion or in cases such as chemotherapy infusion where a stable connect is crucial. Administering IV flushes/boluses through a Luer lock syringe is considered as best clinical practice. The Needle is affixed to the Syringe by twisting it into the Syringe Tip threads to lock it in place. PLAJEX (pre-filled syringes with staked needle) is a product line of Terumo Corporation. In January 2017, a new version was introduced with a Threaded Closure polymer prefillable syringe in its pre-filled syringes product range called PLAJEX Luer Lock. The company is known for developing the world's thinnest NANOPASS 34 needle for self-injection insulin devices. This also emphasizes higher investments on R&D to develop new and innovative products.
Asia Pacific syringe market is expected to grow owing to factors such as growing number of chronic diseases and infectious diseases and increased adoption of injectable drugs. However, the market is likely to have negative impact due to growing cases of needle-stick injuries.
BD, Baxter International Inc., Terumo Corporation, Cardinal Health Inc, Nipro, B. Braun Melsungen AG, INC., HENKE-SASS, WOLF are among the leading companies operating in the Asia Pacific Syringe Market.
The report segments Asia Pacific Syringe Market as follows
By Syringes Type
By Application
By Usability
By End User
By Country
Reasons to Buy
According to a new market research study of “Asia Pacific Syringe Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Syringe Type, Application, Usability, and End User” the Asia Pacific syringe market is projected to reach US$5,946.66 million by 2027 from US$2,654.58 million in 2019. The market is estimated to grow at CAGR of 10.5% from 2020 to 2027. The report highlights trends prevailing in the Asia Pacific syringe market and the factors driving market along with those that act as hindrances.
Based on syringe type, the syringe market is segmented into luer lock syringes, glass syringes, luer slip syringes, and others.
In 2019, the Luer-Lock syringes segment accounted for the highest share of the market in 2019. However, the glass syringes segment is estimated to register the highest CAGR of 11.3% in the market during the forecast period. Growth of this segment is attributed to the increasing adoption of luer lock syringes due to ease of administration and increasing patient pool across the globe. However, glass syringes are likely to register highest CAGR in the global syringes market during the forecast period.
The Luer-Lock syringes used for essential clinical applications in which disengagement of needle is to be avoided in order to prevent medication leakage or spray. A Luer lock syringe allows screw-fixation and is therefore a more convenient to inject. Luer lock syringes are more widely used for using a syringe pump for prolonged IV infusion or in cases such as chemotherapy infusion where a stable connect is crucial. Administering IV flushes/boluses through a Luer lock syringe is considered as best clinical practice. The Needle is affixed to the Syringe by twisting it into the Syringe Tip threads to lock it in place. PLAJEX (pre-filled syringes with staked needle) is a product line of Terumo Corporation. In January 2017, a new version was introduced with a Threaded Closure polymer prefillable syringe in its pre-filled syringes product range called PLAJEX Luer Lock. The company is known for developing the world's thinnest NANOPASS 34 needle for self-injection insulin devices. This also emphasizes higher investments on R&D to develop new and innovative products.
Asia Pacific syringe market is expected to grow owing to factors such as growing number of chronic diseases and infectious diseases and increased adoption of injectable drugs. However, the market is likely to have negative impact due to growing cases of needle-stick injuries.
BD, Baxter International Inc., Terumo Corporation, Cardinal Health Inc, Nipro, B. Braun Melsungen AG, INC., HENKE-SASS, WOLF are among the leading companies operating in the Asia Pacific Syringe Market.
The report segments Asia Pacific Syringe Market as follows
By Syringes Type
- Luer Lock Syringes
- Glass Syringes
- Luer Slip Syringes
- Others
By Application
- Aesthetics
- Human Health
- Lab/Industrial
- Others
By Usability
- Sterilizable/Reusable Syringes
- Disposable Syringes
By End User
- Hospitals & Clinics
- Blood Collection Centers
- Diabetic Care Centers
- Others
By Country
- Japan
- China
- France
- India
- South Korea
- Australia
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific syringe market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific syringe market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets. Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
1. Introduction
3. Research Methodology
4. Asia Pacific Syringes Market- Market Landscape
5. Syringes Market- Key Market Dynamics
6. Syringe Market - Asia Pacific Analysis
7. Syringe Market Analysis - By Syringe Type
8. Syringe Market Analysis - By Application
9. Syringe Market Analysis - By Usability
10. Syringe Market Analysis - By End User
11. Syringe Market - Geographic Analysis
12. Impact of COVID-19 Pandemic on Asia Pacific Syringes Market
13. Company Profiles
14. Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- BD
- Baxter International Inc.
- Terumo Corporation
- Cardinal Health Inc.
- Nipro
- B. Braun Melsungen AG
- HENKE-SASS, WOLF
